Objective To evaluate the potential relationship between outcomes in cervical cancer patients based on distance from our Comprehensive Cancer Center (CCC). Methods A retrospective cohort study of cervical cancer patients was performed. Abstracted data included: demographics, clinicopathologic variables, treatment, and survival. Analyses both by quartiles and distance < 100 and ≥ 100 miles from our institution were performed. Data were analyzed using SAS version 9.2. Results 390 patients living a median distance of 58.1 miles (range 1.2–571 miles) from our CCC were identified. Patients were generally white (n = 249), non-smokers (n = 226), with Stage IB disease (n = 222), squamous histology (n = 295) and underwent primary surgical therapy (n = 229). Patients were divided into both quartiles as well as two strata: < 100 and ≥ 100 miles for comparison. Progression-free survival (PFS) and overall survival (OS) favored patients living closer to our center with a lower median OS for patients living ≥ 100 miles (65.4vs. 99.4 months; p = 0.040). Cox proportional hazard modeling noted that advanced stage was predictive of inferior PFS and OS, while other clinical covariates including age, BMI, race, smoking status and histology had a variable impact on outcomes and distance > 100 miles was associated with a higher risk of death (hazard ratio [HR] = 1.68, 95% confidence interval [CI] 1.11–2.54). Conclusion Overall survival for patients living > 100 miles from our CCC was worse when compared to patients in closer proximity. Outreach efforts and utilization of navigators may help decrease the impact of geographic and racial disparities on outcomes.